Alembic Pharmaceuticals has received a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter and half-year ended September 30, 2025. The certificate was received from MUFG Intime India Private Limited, the Registrar and Share Transfer Agent, confirming compliance with depository regulations.
Certificate of Compliance
Alembic Pharmaceuticals has announced the receipt of a certificate confirming compliance with regulatory requirements related to depositories and participants. This certificate is mandated under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.
Period of Compliance
The certificate pertains to the quarter and half-year period that ended on September 30, 2025. This confirms that Alembic Pharmaceuticals has met the necessary regulatory standards for this period.
Registrar and Transfer Agent
The certificate was issued by MUFG Intime India Private Limited, the Registrar and Share Transfer Agent for Alembic Pharmaceuticals. MUFG Intime has verified and confirmed that securities received for dematerialization have been duly processed.
Confirmation of Dematerialization
MUFG Intime confirms that securities received from depository participants for dematerialization during the quarter ended September 30th, 2025, were processed according to regulations. They further confirm that the security certificates received for dematerialization have been confirmed, mutilated, and cancelled after verification, with the names of the depositories substituted in the register of members.
Source: BSE
